TrianglePUBLICATIONS · 25332249
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2014 Nov 20
- First author
- Perez EA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Perez EA
- type
- Author
- name
- Romond EH
- type
- Author
- name
- Suman VJ
- type
- Author
- name
- Jeong JH
- type
- Author
- name
- Sledge G
- type
- Author
- name
- Geyer CE Jr
- type
- Author
- name
- Martino S
- type
- Author
- name
- Rastogi P
- type
- Author
- name
- Gralow J
- type
- Author
- name
- Swain SM
- type
- Author
- name
- Winer EP
- type
- Author
- name
- Colon-Otero G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Perez EA
- type
- Author
- name
- Romond EH
- type
- Author
- name
- Suman VJ
- type
- Author
- name
- Jeong JH
- type
- Author
- name
- Sledge G
- type
- Author
- name
- Geyer CE Jr
- type
- Author
- name
- Martino S
- type
- Author
- name
- Rastogi P
- type
- Author
- name
- Gralow J
- type
- Author
- name
- Swain SM
- type
- Author
- name
- Winer EP
- type
- Author
- name
- Colon-Otero G
- type
- Author
- bibliography ids
- nci-bib-970b3f10a6b24646ae1d10b5
- book metadata
- content sha256
- 79ebcc689f2f1803a386ab29cd2e05302403cd3cd06a0ce04c03f15c987ee935
- document type
- citation
- dois
- 10.1200/JCO.2014.55.5730
- electronic publication date
- display
- 2014 Oct 20
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25332249
- immutable id
- pubmed:25332249@79ebcc689f2f1803a386ab29cd2e05302403cd3cd06a0ce04c03f15c987ee935
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 33
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3744-52
- volume
- 32
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25332249
- provenance
- batch id
- 863b068fe5a07222af6a
- provider
- NCBI PubMed ESummary
- record sha256
- b94f818eb1fb2ada1d7e84cb0fe2ea61ae7a793ee9b6aaeefa48d94b26ac9421
- response sha256
- 80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
- retrieved at
- 2026-09-09T23:47:07.648963+00:00
- publication date
- display
- 2014 Nov 20
- precision
- day
- year
- 2014
- publication types
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.
Preserved source evidence · Not medical advice